^aDivisión de Enfermedades Cardiovasculares, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

^bMillennium Institute of Immunology and Immunotherapy

^cInstituto de Ciencias Biomedicas, Facultad de Medicina

^dAdvanced Center for Chronic Diseases (ACCDiS) and Centro Estudios Moleculares de la Celula, Facultad Ciencias Quimicas y Farmaceuticas and Facultad Medicina, Universidad de Chile, Santiago, Chile

^eCardiology Division, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Correspondence to María Paz Ocaranza, PhD, División de Enfermedades Cardiovasculares, Escuela de Medicina, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago 8330024, Chile. E-mail: [email protected]

Received 11 April, 2014

Revised 17 April, 2014

Accepted 17 April, 2014